Bill Summary
H.R. 4837, the Written Informed Consent Act, directs the Secretary of Veterans Affairs to update Veterans Health Administration Directive 1005—which currently requires written informed consent only for long-term opioid therapy—so that it also covers five additional medication classes: antipsychotics, stimulants, antidepressants, anxiolytics, and narcotics. Under the bill, VA clinicians would need to provide veterans with clear written information about the risks, side effects, and alternatives to these drugs and obtain a signed consent form before starting treatment, bringing these high‑risk psychiatric and pain medications under the same structured informed‑consent process already used for long‑term opioids. The goal is to enhance safety, transparency, and documentation around prescribing powerful medications that can affect mental health, cognition, dependence risk, and long‑term quality of life.
H.R. 4837, the Written Informed Consent Act, directs the Secretary of Veterans Affairs to update Veterans Health Administration Directive 1005—which currently requires written informed consent only for long-term opioid therapy—so that it also covers five additional medication classes: antipsychotics, stimulants, antidepressants, anxiolytics, and narcotics. Under the bill, VA clinicians would need to provide veterans with clear written information about the risks, side effects, and alternatives to these drugs and obtain a signed consent form before starting treatment, bringing these high‑risk psychiatric and pain medications under the same structured informed‑consent process already used for long‑term opioids. The goal is to enhance safety, transparency, and documentation around prescribing powerful medications that can affect mental health, cognition, dependence risk, and long‑term quality of life.
Why It Matters to the Make America Healthy Again Movement
The MAHA Movement supports this bill because it strengthens veterans’ right to understand and consent before being placed on potent psychiatric and pain drugs that can carry severe side effects and withdrawal challenges. By extending written informed‑consent requirements beyond opioids to include antipsychotics, stimulants, antidepressants, anxiolytics, and narcotics, H.R. 4837 aligns with MAHA’s call for transparency, caution in pharmaceutical prescribing, and genuine patient autonomy—especially for veterans who are often overmedicated instead of offered holistic, root‑cause care.